ECCO-IBUS Research Grant supports clinical investigators studying intestinal ultrasound in inflammatory bowel disease to strengthen evidence for its use in patient assessment and monitoring.
Funder: European Crohn’s and Colitis Organisation
Due Dates: March 1, 2026 (Submissions open) | October 31, 2026 (Application deadline) | Early 2027 (Funding notification) | March 2027 (Official award announcement)
Funding Amounts: €40,000 total annual funding; studies must be completed within 2 years
Summary: Supports clinical research on intestinal ultrasound’s utility in assessing patients with inflammatory bowel disease.
Key Information: Applicants must be ECCO or IBUS members at submission, established in an expert IBD clinical unit, and have routine ultrasound access.
The ECCO-IBUS Research Grant is jointly run by the European Crohn’s and Colitis Organisation (ECCO) and the International Bowel Ultrasound Group (IBUS). It supports member investigators conducting clinical research on the utility of intestinal ultrasound in assessing patients with inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
The programme aims to strengthen the scientific evidence supporting intestinal ultrasound and increase its acceptance as a cost-effective, well-tolerated and repeatable monitoring tool. Its focus reflects treatment targets extending beyond symptom control to healing visible through cross-sectional imaging. Funded work has explored monitoring inflammation and treatment response, assessing inflammation and fibrosis in stricturing Crohn’s disease, and transperineal ultrasound in proctitis and perianal disease.